Literature DB >> 21600367

Thinking and talking about life expectancy in incurable cancer.

Belinda E Kiely1, Martin R Stockler, Martin H N Tattersall.   

Abstract

Most patients with incurable cancer want information about the impact cancer will have on their future, and many want specific estimates of the most likely, best case, and worst case scenarios for survival. With improved understanding of life expectancy, patients are better equipped to make appropriate treatment decisions and plans for the future. Although physicians acknowledge that patients with incurable cancer want prognostic information and benefit from this, most struggle to provide it and experience difficulty in making reliable estimates, communicating them, and tailoring the information to the individual patient. In this review we address some of the implications that arise from thinking and talking about life expectancy with people who have incurable cancer, particularly those considering first- or second-line chemotherapy. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600367     DOI: 10.1053/j.seminoncol.2011.03.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

1.  The Lake Wobegon effect: are all cancer patients above average?

Authors:  Jacqueline H Wolf; Kevin S Wolf
Journal:  Milbank Q       Date:  2013-12       Impact factor: 4.911

2.  Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data.

Authors:  Rafael Santana-Davila; Aniko Szabo; Carlos Arce-Lara; Christina D Williams; Michael J Kelley; Jeff Whittle
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

3.  To Treat or Not to Treat.

Authors:  Yeh Chen Lee; Alison Davis
Journal:  JNCI Cancer Spectr       Date:  2019-04-15

4.  Protocol for the ORaClES study: an online randomised controlled trial to improve clinical estimates of survival using a training resource for medical students.

Authors:  Linda Oostendorp; Nicola White; Priscilla Harries; Sarah Yardley; Christopher Tomlinson; Federico Ricciardi; Hulya Gokalp; Patrick Stone
Journal:  BMJ Open       Date:  2019-03-03       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.